BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 6722226)

  • 21. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dexamethasone suppression in the depressed patient. Reflections apropos of an experience].
    Jonas C; Etienne T; Valat C
    Encephale; 1983; 9(2):111-22. PubMed ID: 6641613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of cortisol, corticotropin, and beta-endorphin in patients with major depression.
    Lin SC; Maruta T; Newman DC; Kao PC
    J Clin Psychiatry; 1986 Aug; 47(8):413-4. PubMed ID: 3015893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS; Ko HC; Lu RB
    Biol Psychiatry; 1998 Oct; 44(7):648-55. PubMed ID: 9787892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of the cortisol suppression index in depression.
    Bernstein JP; Chung SY
    J Clin Psychiatry; 1984 Oct; 45(10):433-6. PubMed ID: 6480569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to dexamethasone in affective disorder outpatients.
    Steardo L; Cardone G; Casiello M; Sorge F; Muscettola G
    Acta Psychiatr Belg; 1984; 84(3):218-27. PubMed ID: 6485840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The overnight dexamethasone suppression test: clinical and theoretical review.
    Gwirtsman H; Gerner RH; Sternbach H
    J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical complaints correlate better with depression than do dexamethasone suppression test results.
    Silver H
    J Clin Psychiatry; 1986 Apr; 47(4):179-81. PubMed ID: 3957876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
    Reus VI
    Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dexamethasone suppression test in psychiatry.
    Joyce PR; Brinded PJ; Sellman D; Donald RA; Elder PA
    N Z Med J; 1987 Mar; 100(820):173-5. PubMed ID: 3452036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV; Hwu HG; Clayton PJ
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
    Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ
    Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone suppression test in children with major depressive disorder.
    Birmaher B; Ryan ND; Dahl R; Rabinovich H; Ambrosini P; Williamson DE; Novacenko H; Nelson B; Lo ES; Puig-Antich J
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):291-7. PubMed ID: 1564032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cortisol suppression index and the dexamethasone suppression test in major depression.
    Maes M; De Ruyter M; Suy E
    Acta Psychiatr Belg; 1987; 87():633-9. PubMed ID: 3452982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.